Topical drug delivery systems in dermatology: a review of patient adherence issues

Bibliography

• Vrijens B, De Geest S, Hughes DA, A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 2012;73(5):691-705
   PubMed Web of Science ®Google Scholar
• World Health Organisation S. Adherence to long-term therapies: evidence for action. World Health Organization; Geneva, Switzerland: 2003
   Google Scholar
• Berry SD, Quach L, Procter-Gray E, Poor Adherence to medications may be associated with falls. J Gerontol A Biol Sci Med Sci 2010;65A(5):553-8
   Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353(5):487-97
   PubMed Web of Science ®Google Scholar
• Nolan BV, Feldman SR. Dermatologic medication adherence. Dermatol Clin 2009;27(2):113-20
   PubMed Web of Science ®Google Scholar
• Carroll CL, Feldman SR, Camacho FT, Balkrishnan R. Better medication adherence results in greater improvement in severity of psoriasis. Br J Dermatol 2004;151(4):895-7
   PubMed Web of Science ®Google Scholar
• Wolf J. Medication adherence: a key factor in effective management of rosacea. Adv Ther 2001;18(6):272-81
   PubMed Web of Science ®Google Scholar
• Fischer G. Compliance problems in paediatric atopic eczema. Australa J Dermatol 1996;37:S10-13
   PubMedGoogle Scholar
• Kinney MA, Feldman SR. What's new in the management of psoriasis? G Ital Dermatol Venereol 2009;144(2):103-17
   PubMed Web of Science ®Google Scholar
• Dréno B, Thiboutot D, Gollnick H, Large-scale worldwide observational study of adherence with acne therapy. Int J Dermatol 2010;49(4):448-56
   PubMed Web of Science ®Google Scholar
• Yentzer BA, Ade RA, Fountain JM, Simplifying regimens promotes greater adherence and outcomes with topical acne medications: a randomized controlled trial. Cutis (New York, N.Y.) 2010;86(2):103
   Google Scholar
• Cork MJ, Britton J, Butler L, Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol 2003;149(3):582-9
   PubMed Web of Science ®Google Scholar
• Balkrishnan R, Carroll CL, Camacho FT, Feldman SR. Electronic monitoring of medication adherence in skin disease: results of a pilot study. J Am Acad Dermatol 2003;49(4):651-4
   PubMed Web of Science ®Google Scholar
• Carroll CL, Feldman SR, Camacho FT, Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol 2004;51(2):212-16
   PubMed Web of Science ®Google Scholar
• Storm A, Andersen SE, Benfeldt E, Serup J. One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic. J Am Acad Dermatol 2008;59(1):27-33
   PubMed Web of Science ®Google Scholar
• van de Kerkhof PCM, de Hoop D, de Korte J, Patient Compliance and disease management in the treatment of psoriasis in the Netherlands. Dermatology 2000;200(4):292-8
   PubMed Web of Science ®Google Scholar
• Cook-Bolden F, Eichenfield LF, Fried R, Phase 4 study to assess tretinoin pump for the treatment of facial acne. J Drugs Dermatol 2008;7(12):1129-36
   PubMedGoogle Scholar
• Pawin H, Beylot C, Chivot M, Creation of a tool to assess adherence to treatments for acne. Dermatology 2009;218(1):26-32
   PubMed Web of Science ®Google Scholar
• Marazzi P, Boorman GC, Donald AE, Davies HD. Clinical evaluation of double strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris. J Dermatolog Treat 2002;13(3):111-17
   PubMed Web of Science ®Google Scholar
• Cunliffe WJ, Fernandez C, Bojar R, An observer blind, parallel group, randomized, multicentre clinical and microbiological study of a topical clindamycin/zinc gel and a topical clindamycin lotion in patients with mild/moderate acne. J Dermatolog Treat 2005;16(4):213-18
   PubMed Web of Science ®Google Scholar
• McEvoy B, Nydegger R, Williams G. Factors related to patient compliance in the treatment of acne vulgaris. Int J Dermatol 2003;42(4):274-80
   PubMed Web of Science ®Google Scholar
• Zaghloul SS, Cunliffe WJ, Goodfield MJD. Objective assessment of compliance with treatments in acne. Br J Dermatol 2005;152(5):1015-21
   PubMed Web of Science ®Google Scholar
• Krejci-Manwaring J, Tusa MG, Carroll C, Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol 2007;56(2):211-16
   PubMed Web of Science ®Google Scholar
• Serup J, Kettis Lindblad A, Maroti M, To follow or not to follow dermatological treatment- A review of the literature. Acta Dermatol Venereol 2006;86(3):193-7
   PubMed Web of Science ®Google Scholar
• Krejci-Manwaring J, McCarty MA, Camacho F, Adherence with topical treatment is poor compared with adherence with oral agents: implications for effective clinical use of topical agents. J Am Acad Dermatol 2006;54(5):S235-6
   PubMedGoogle Scholar
• Storm A, Benfeldt E, Andersen SE, Serup J. A prospective study of patient adherence to topical treatments: 95% of patients underdose. J Am Acad Dermatol 2008;59(6):975-80
   PubMed Web of Science ®Google Scholar
• Gupta G, Mallefet P, Kress DW, Sergeant A. Adherence to topical dermatological therapy: lessons from oral drug treatment. Br J Dermatol 2009;161(2):221-7
   PubMed Web of Science ®Google Scholar
• Feldman SR, Horn EJ, Balkrishnan R, Psoriasis: improving adherence to topical therapy. J Am Acad Dermatol 2008;59(6):1009-16
   PubMed Web of Science ®Google Scholar
• Richards HL, Fortune DG, O'Sullivan TM, Patients with psoriasis and their compliance with medication. J Am Acad Dermatol 1999;41(4):581-3
   PubMed Web of Science ®Google Scholar
• Brown KK, Rehmus WE, Kimball AB. Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis. J Am Acad Dermatol 2006;55(4):607-13
   PubMed Web of Science ®Google Scholar
• Ivens UI, Steinkjer B, Serup J, Tetens V. Ointment is evenly spread on the skin, in contrast to creams and solutions. Br J Dermatol 2001;145(2):264-7
   PubMed Web of Science ®Google Scholar
• Augustin M, Holland B, Dartsch D, Adherence in the treatment of psoriasis: a systematic review. Dermatology 2011;222(4):363-74
   PubMed Web of Science ®Google Scholar
• Feldman SR, Camacho FT, Krejci-Manwaring J, Adherence to topical therapy increases around the time of office visits. J Am Acad Dermatol 2007;57(1):81-3
   PubMed Web of Science ®Google Scholar
• Lott R, Taylor SL, O'Neill JL, Medication adherence among acne patients: a review. J Cosmet Dermatol 2010;9(2):160-6
   PubMed Web of Science ®Google Scholar
• Baker M, Tuley M, Busdiecker FL, Adapalene gel 0.1% is effective and well tolerated in acne patients in a dermatology practice setting. Cutis 2001;68(4 Suppl):41-7
   PubMedGoogle Scholar
• Yentzer BA, Alikhan A, Teuschler H, An exploratory study of adherence to topical benzoyl peroxide in patients with acne vulgaris. J Am Acad Dermatol 2009;60(5):879-80
   PubMed Web of Science ®Google Scholar
• Baldwin HE. Tricks for improving compliance with acne therapy. Dermatol Ther 2006;19(4):224-36
   PubMed Web of Science ®Google Scholar
• Lee IA, Maibach HI. Pharmionics in dermatology: a review of topical medication adherence. Am J Clin Dermatol 2006;7(4):231-6
   PubMed Web of Science ®Google Scholar
• Jones-Caballero M, Pedrosa E, Peñas PF. Self-reported adherence to treatment and quality of life in mild to moderate acne. Dermatology 2008;217(4):309-14
   PubMed Web of Science ®Google Scholar
• Misery L. Why is there poor adherence to topical corticosteroid therapy in atopic dermatitis? Expert Rev Dermatol 2012;7(1):5-7
   Google Scholar
• Aubert-Wastiaux H, Moret L, Le Rhun A, Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency. Br J Dermatol 2011;165(4):808-14
   PubMed Web of Science ®Google Scholar
• Yentzer BA, Camacho FT, Young T, Good adherence and early efficacy using desonide hydrogel for atopic dermatitis: results from a program addressing patient compliance. J Drugs Dermatol 2010;9(4):324-9
   PubMed Web of Science ®Google Scholar
• Koehler AM, Maibach HI. Electronic monitoring in medication adherence measurement: implications for dermatology. Am J Clin Dermatol 2001;2(1):7
   PubMedGoogle Scholar
• Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol 2004;19(4):357-62
   PubMed Web of Science ®Google Scholar
• Haynes RB, Ackloo E, Sahota N, Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews 2008;2. Art. No.: CD000011. DOI: 10.1002/14651858.CD000011.pub3.
   Google Scholar
• Hodari KT, Nanton JR, Carroll CL, Adherence in dermatology: a review of the last 20 years. J Dermatolog Treat 2006;17(3):136-42
   PubMed Web of Science ®Google Scholar
• Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol 2000;142(5):931-6
   PubMed Web of Science ®Google Scholar
• Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med 1990;150(7):1509-10
   PubMed Web of Science ®Google Scholar
• Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med 1990;150(7):1377-8
   PubMed Web of Science ®Google Scholar
• Kass MA, Meltzer D, Gordon M, Compliance with topical pilocarpine treatment. Am J Ophthalmol 1986;101(5):515-23
   PubMed Web of Science ®Google Scholar
• Cutrona SL, Choudhry NK, Fischer MA, Modes of delivery for interventions to improve cardiovascular medication adherence. Am J Manag Care 2010;16(12):929-42
   PubMed Web of Science ®Google Scholar
• Fjeldsoe BS, Marshall AL, Miller YD. Behavior change interventions delivered by mobile telephone short-message service. Am J Prev Med 2009;36(2):165-73
   PubMed Web of Science ®Google Scholar
• Hibbard JH, Mahoney ER, Stock R, Tusler M. Do increases in patient activation result in improved self-management behaviors? Health Serv Res 2007;42(4):1443-63
   PubMed Web of Science ®Google Scholar
• Feldman SR, Housman TS. Patients' vehicle preference for corticosteroid treatments of scalp psoriasis. Am J Clin Dermatol 2003;4:221-4
   PubMed Web of Science ®Google Scholar
• Kircik LH. Importance of vehicles in acne therapy. J Drugs Dermatol 2011;10(6):s17-s23
   PubMed Web of Science ®Google Scholar
• Buhse L, Kolinski R, Westenberger B, Topical drug classification. Int J Pharm 2005;295(1–2):101-12
   PubMed Web of Science ®Google Scholar
• Kurian A, Barankin B. Delivery Vehicle Advances in Dermatology. 2011. Available from: http://www.skintherapyletter.com/fp/2011/7.2/2.html [Accessed 30 May 2012]
   Google Scholar
• Bewley A, Page B. Maximizing patient adherence for optimal outcomes in psoriasis. J Eur Acad Dermatol Venereol 2011;25:9-14
   PubMed Web of Science ®Google Scholar
• van de Kerkhof PCM, Kragballe K, Segaert S, Lebwohl M; for the International Psoriasis Council. Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the international psoriasis council. J Eur Acad Dermatol Venereol 2011;25(10):1130-9
   PubMed Web of Science ®Google Scholar
• Kahanek NR, Gelbard CG, Hebert AA. Desonide: a review of formulations, efficacy and safety. Expert Opin Investig Drugs 2008;17(7):1097-104
   PubMed Web of Science ®Google Scholar
• Nighland M, Yusuf M, Wisniewski S, The effect of simulated solar UV irradiation on tretinoin in tretinoin gel microsphere 0.1% and tretinoin gel 0.025%. Cutis 2006;77(5):313-16
   PubMed Web of Science ®Google Scholar
• Nyirady J, Lucas C, Yusuf M, The stability of tretinoin in tretinoin gel microsphere 0.1%. Cutis 2002;70(5):295-8
   PubMed Web of Science ®Google Scholar
• Wester RC, Patel R, Nacht S, Controlled release of benzoyl peroxide from a porous microsphere polymeric system can reduce topical irritancy. J Am Acad Dermatol 1991;24(5 Part 1):720-6
   PubMed Web of Science ®Google Scholar
• Koo JYM. Relevance of the COBRA trial in current psoriasis practice. Cutis (New York, N.Y.) 2007;80(5):4
   Google Scholar
• West CE, Narahari S, Feldman SR. Calcipotriene foam, 0.005% in mild-to-moderate plaque psoriasis. Expert Rev Dermatol 2012;7(1):17-26
   Google Scholar